Phaarmasia Ltd.
Snapshot View

View in App

Prices View details >>

25.90 -0.10 ▼-0.4%

21 March 2023, 04:01:00 PM
Volume: 324

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.phaarmasia.in
Market Cap 17.68 Cr.
Enterprise Value(EV) 16.32 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -1.93 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 9.74 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.66 Calculated using Price: 25.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.68 Cr. 6,826,960 Shares
FaceValue 10
Company Profile
The company was incorporated on February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.38%
1 Week
+15.68%
1 Month
+1.37%
3 Month
-13.67%
6 Month
+4.86%
1 Year
-9.12%
2 Year
-8.32%
5 Year
-30.75%
10 Year
+102.19%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.71 1.86 0.55 2.16 7.54 9.51 6.08 3.36 -17.96
Return on Capital Employed (%) 6.12 5.28 3.35 3.63 9.32 10.35 11.07 5.24 -18.00
Return on Assets (%) 1.86 0.86 0.22 0.85 2.76 2.82 1.61 1.12 -7.18

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 13 12 12 12 13 13 14 12 11
Non Curr. Liab. 0 0 0 1 1 1 1 0 0 0
Curr. Liab. 6 6 6 7 9 20 19 8 9 14
Minority Int.
Equity & Liab. 13 19 19 20 22 33 34 22 21 26
Non Curr. Assets 11 16 14 14 14 14 14 13 13 13
Curr. Assets 3 3 4 6 8 19 20 9 8 13
Misc. Exp. not W/O
Total Assets 13 19 19 20 22 33 34 22 21 26

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 21 19 22 14 20 24 24 20 17 24
Other Income 0 1 1 1 1 1 1 0 1
Total Income 21 19 22 15 21 25 25 21 18 25
Total Expenditure -20 -18 -21 -14 -20 -23 -24 -20 -19 -26
PBIDT 1 1 1 1 1 1 1 1 -1 -1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 -1 -1 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 0 1 1 1 0 -2 -1
Adjusted EPS 1 0 0 0 1 1 1 0 -2 -2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 1 0 0 0 0
Cash Fr. Inv. 0 0 0 0 0 -1 0
Cash Fr. Finan. 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 73.45 73.51 73.51 73.51 73.51 73.51 73.51 73.51 73.51
Public 26.55 26.49 26.49 26.49 26.49 26.49 26.49 26.49 26.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 23 Feb 2023
Post-Offer Public Announcement
Saffron Capital Advisors Pvt Ltd ("Manager to the Delisting Offer") has submitted to BSE a copy of Post-Offer Public Announcement for the attention of the Equity Shareholders of Phaarmasia Ltd ("Target Company").
Thu, 23 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
The delisting offer opened on Wednesday February 15 2023 and closed on Tuesday February 21 2023 at the end of the market hours on BSE. The Floor Price for the Delisting Offer was determined as ? 24 per equity share and the Indicative Price was determined as ? 25 per equity share.We hereby wish to inform you that with the Reverse Book Building Process the minimum number of shares are not tendered/offered as provided under clause (a) of Regulation 21 and the Post Delisting Offer the shareholding of the Promoter Acquirer along with the other promoters and promoter group did not exceeded 90% of total issued number of equity shares (excluding shares held by inactive shareholders etc.) therefore the Delisting Offer is considered as failed.In this regard we have received from Saffron Capital Advisors Private Limited Manager to the Offer on behalf of promoter Acquirer a copy of the Post Offer Public Announcement (Post Offer PA) published on Thursday February 23 2023.
Tue, 21 Feb 2023
Outcome of Reverse Book Building Process
Saffron Capital Advisors Pvt Ltd ("Manager to the Delisting Offer") has submitted to BSE regarding "Outcome of Reverse Book Building Process under Regulation 17(3) of the SEBI (Delisting of Equity Shares) Regulations 2021 (SEBI Delisting Regulations)."

Technical Scans View Details >>

Tue, 21 Mar 2023
Opening at High Opening at High
Close Above Last Week High Close Above Last Week High
High Decrease in 3 Months High Decrease in 3 Months
Closing Near 50 SMA Closing Near 50 SMA
CCI Overbought Zone CCI Overbought Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,419.30 -0.5%
Divi's Laboratories Ltd. 73,553.38 2,773.45 -0.9%
Cipla Ltd. 69,632.88 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,378.30 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 26.39 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 3.07 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Phaarmasia Ltd.

What is Phaarmasia share price?
Can I buy Phaarmasia shares now?
What is the Market Cap of Phaarmasia?
What are the key metrics to analyse Phaarmasia?
What is the 52 Week High and Low of Phaarmasia?
What is the trend of Phaarmasia share price?